Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Current Deferred Revenue (2019 - 2026)

Outset Medical has reported Current Deferred Revenue over the past 7 years, most recently at $13.8 million for Q4 2025.

  • Quarterly Current Deferred Revenue rose 8.17% to $13.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.8 million through Dec 2025, up 8.17% year-over-year, with the annual reading at $13.8 million for FY2025, 8.17% up from the prior year.
  • Current Deferred Revenue was $13.8 million for Q4 2025 at Outset Medical, down from $14.9 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $14.9 million in Q3 2025 and troughed at $3.5 million in Q1 2021.
  • The 5-year median for Current Deferred Revenue is $10.8 million (2023), against an average of $10.0 million.
  • Year-over-year, Current Deferred Revenue surged 98.06% in 2021 and then rose 2.73% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $6.3 million in 2021, then skyrocketed by 36.62% to $8.7 million in 2022, then soared by 35.38% to $11.7 million in 2023, then increased by 8.75% to $12.8 million in 2024, then grew by 8.17% to $13.8 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Current Deferred Revenue are $13.8 million (Q4 2025), $14.9 million (Q3 2025), and $14.0 million (Q2 2025).